PACIRA BIOSCIENCES IN

17,42

25-ноября-24 16:45:01

15 мин. задержка

Акции

-0,13

-0,74%

Сегодняшний диапазон

17,41 - 18,09

ISIN

N/A

Источник

NASDAQ

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

09 июл 2024 09:45:29 Источник NetDania Notify
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

02 июл 2024 09:54:55 Источник NetDania Notify
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference

30 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029

10 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes

08 май 2024 16:05:14 Источник Nasdaq GlobeNewswire
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program

07 май 2024 16:00:00 Источник Nasdaq GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

07 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024

30 апр 2024 08:00:01 Источник Nasdaq GlobeNewswire
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

25 апр 2024 09:45:09 Источник NetDania Notify
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

22 апр 2024 11:49:23 Источник NetDania Notify
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

15 апр 2024 11:02:15 Источник NetDania Notify
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

02 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee

13 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference

06 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results

29 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira to Report 2023 Financial Results on Thursday February 29, 2024

22 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy

15 фев 2024 08:36:16 Источник Nasdaq GlobeNewswire
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

07 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues

04 янв 2024 17:00:41 Источник Nasdaq GlobeNewswire
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 янв 2024 08:00:01 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.